Skip to main content
Clinical Trials/NCT04364295
NCT04364295Enrolling By InvitationNot Applicable

Evaluating Real-World Spine Outcomes for Spinal and Orthobiologics Products From Around the World

SeaSpine, Inc.2 sites in 1 country2,285 target enrollmentStarted: March 20, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
2,285
Locations
2
Primary Endpoint
Evaluation of product failure

Study Overview

Brief Summary

A global, prospective, non-randomized, multicenter, observational, post-market, medical record review registry evaluating real-world evidence for SeaSpine products.

Detailed Description

To gain observational, prospective, real-world clinical, and radiographic data in order to evaluate continued safety and performance following the implantation of SeaSpine products.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Have been treated with at least one SeaSpine product.
  • Have obtained radiographic imaging, as part of the standard of care, at the following time points: preoperative and postoperative.
  • Have obtained at least one preoperative patient-reported outcome measure, as part of the standard of care.
  • Patient is planned, per standard of care, to be assessed with radiographic imaging and consistent patient-reported outcome measure(s) from preoperative through at least two scheduled follow-up visits.

Exclusion Criteria

  • Was not implanted with at least one SeaSpine product during operation
  • Any other condition that the Investigator determines is unacceptable for enrollment into this registry

Outcomes

Primary Outcomes

Evaluation of product failure

Time Frame: 12 months post-operative

Product failure is defined as product fracture, loosening, gross migration and/or dissociation.

Secondary Outcomes

  • Incidence of product-related Serious Adverse Events (SAEs) related to the spine, fusion or bone healing, and intraoperative and postoperative unanticipated adverse device effects(Intra-operative to 24 months)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Stronger Together Global Registry | Clinical Trial